**Specifications table**TableSubject area*Chemistry*More specific subject area*Natural products*Type of data*Figure*How data was acquired*NMR spectroscopy: JEOL A400; HRESIMS: Thermo Fisher Scientific LTQ Orbitrap XL mass spectrometer; High-performance liquid chromatography (HPLC)-photodiode array (PDA) analyses: Inertsil ODS-3 column (150*×*4.6 mm i.d., 5* *μm) on a JASCO LC-2000 instrument equipped with a JASCO MD-2015 multiwavelength detector.*Data format*Analyzed*Experimental factors*The undescribed hydroxylated furanoditerpenoids were purified by column chromatography.*Experimental features*The isolated compounds were characterized by HRESIMS and NMR spectroscopy*Data source location*Higashi-Hiroshima, Japan*Data accessibility*Data are available with this article*Related research article*Y. Akihara, S. Kamikawa, Y. Harauchi, E. Ohta, T. Nehira, H. Ômura, S. Ohta, Hydroxylated furanoditerpenoids from pupal cases produced by the bruchid beetle Sulcobruchus sauteri inside the seeds of Caesalpinia decapetala, Phytochemistry 156 (2018) 151--158.*

**Value of the data**•The data presents HPLC profiles, NMR data, and HRESIMS data of newly isolated furanoditerpenoids and could be used by other researchers.•The provided information on the spectroscopic data of furanoditerpenoids could be useful for the analysis of spectra and determination of the structure of other furanoditerpenoids.•This data can serve as a benchmark for other researchers to elucidate the structures of furanoditerpenoids.

1. Data {#s0005}
=======

The data set presented in this article focuses on characterization of the cassane-type furanoditerpenoids described in [@bib1]. The article provides the information on the high-performance liquid chromatography (HPLC) profiles and spectroscopic data of the isolated furanoditerpenoids. The HPLC profiles of the furanoditerpenoids **1**--**4** shown in [Fig. 1](#f0005){ref-type="fig"} isolated from the EtOAc-soluble fraction of the intact seeds of *Caesalpinia decapetala* are given in [Fig. 2](#f0010){ref-type="fig"} [@bib2], [@bib3], [@bib4]. The HPLC profiles of the furanoditerpenoids **5**--**11** shown in [Fig. 3](#f0015){ref-type="fig"} isolated from the EtOAc-soluble fraction of the pupal cases produced by *Sulcobruchus sauteri* are given in [Fig. 4](#f0020){ref-type="fig"}. [Figs. 5](#f0025){ref-type="fig"}a--g, [6](#f0030){ref-type="fig"}a--g, [7](#f0035){ref-type="fig"}a--g, [8](#f0040){ref-type="fig"}a--g, [9](#f0045){ref-type="fig"}a--g, [10](#f0050){ref-type="fig"}a--g, and [11](#f0055){ref-type="fig"}a--g show 1D NMR, 2D NMR, and HRESIFTMS of the undescribed furanoditerpenoids **5**--**11**. Analyses of the spectra of **5**--**11** are described in the research article [@bib1].Fig. 1Structures of furanoditerpenoids isolated from the intact seeds of *C. decapetala*.Fig. 1Fig. 2HPLC profiles of a) the EtOAc-soluble fraction of the intact seeds of *C. decapetala*, b) caesaljaponin B (**2**), c) caesaljaponin A (**1**), d) caesalacetal (**3**), and e) caesaljapin (**4**).Fig. 2Fig. 3Structures of furanoditerpenoids isolated from the pupal cases produced by *S. sauteri*.Fig. 3Fig. 4HPLC profiles of a) the EtOAc-soluble fraction of the pupal case produced by *S. sauteri*, b) norcaesalsauterol (**11**), c) 2,7-dihydroxycaesaljapin (**7**), d) caesalsauteolide (**5**), e) caesalsauterol (**9**), f) 2-hydroxycaesalacetal (**8**), g) 6-acetylcaesalsauterol (**10**), and h) 2-hydroxycaesaljapin (**6**).Fig. 4Fig. 5**a.**^1^H NMR (400 MHz, CD~3~OD) of **5. b.**^13^C NMR and DEPT (100 MHz, CD~3~OD) of **5. c.**^1^H-^1^H COSY of **5. d.** NOESY of **5. e.** HSQC of **5. f.** HMBC of **5. g.** (+)HRESIFTMS of **5**.Fig. 5Fig. 6**a.**^1^H NMR (400 MHz, CD~3~OD) of **6. b.**^13^C NMR and DEPT (100 MHz, CD~3~OD) of **6. c.**^1^H-^1^H COSY of **6. d.** NOESY of **6. e.** HSQC of **6. f.** HMBC of **6. g.** (-)HRESIFTMS of **6**.Fig. 6Fig. 7**a.**^1^H NMR (400 MHz, CD~3~OD) of **7. b.**^13^C NMR and DEPT (100 MHz, CD~3~OD) of **7. c.**^1^H-^1^H COSY of **7. d.** NOESY of **7. e.** HSQC of **7. f.** HMBC of **7. g.** (-)HRESIFTMS of **7**.Fig. 7Fig. 8**a.**^1^H NMR (400 MHz, CD~3~OD) of **8. b.**^13^C NMR and DEPT (100 MHz, CD~3~OD) of **8. c.**^1^H-^1^H COSY of **8. d.** NOESY of **8. e.** HSQC of **8. f.** HMBC of **8. g.** (+)HRESIFTMS of **8**.Fig. 8Fig. 9**a.**^1^H NMR (400 MHz, CD~3~OD) of **9. b.**^13^C NMR and DEPT (100 MHz, CD~3~OD) of **9. c.**^1^H-^1^H COSY of **9. d.** NOESY of **9. e.** HSQC of **9. f.** HMBC of **9. g.** (+)HRESIFTMS of **9**.Fig. 9Fig. 10**a.**^1^H NMR (400 MHz, CD~3~OD) of **10. b.**^13^C NMR and DEPT (100 MHz, CD~3~OD) of **10. c.**^1^H-^1^H COSY of **10. d.** NOESY of **10. e.** HSQC of **10. f.** HMBC of **10. g.** (+)HRESIFTMS of **10**.Fig. 10Fig. 11**a.**^1^H NMR (400 MHz, CD~3~OD) of **11. b.**^13^C NMR and DEPT (100 MHz, CD~3~OD) of **11. c.**^1^H-^1^H COSY of **11. d.** NOESY of **11. e.** HSQC of **11. f.** HMBC of **11. g.** (+)HRESIFTMS of **11**.Fig. 11

2. Experimental design, materials, and methods {#s0010}
==============================================

NMR spectra were acquired using a JEOL A400 spectrometer (400 MHz for ^1^H, 100 MHz for ^13^C). ^1^H and ^13^C NMR chemical shifts were referenced to residual solvent peaks: *δ*~H~ 3.30 (residual CHD~2~OD) and *δ*~C~ 49.0 for CD~3~OD. HRESIMS were carried out using a Thermo Fisher Scientific LTQ Orbitrap XL mass spectrometer at the Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University. HPLC-photodiode array (PDA) analyses were performed with an Inertsil ODS-3 column (150×4.6 mm i.d., 5 μm) on a JASCO LC-2000 instrument equipped with a JASCO MD-2015 multiwavelength detector. The solvents, (A) CH~3~CN and (B) 1% AcOH, were used as the mobile phase in the following gradient elution: 0--5 min, 60% A; 5--45 min, 60--80% A; 45--55 min 80--100% A with a flow rate of 0.6 ml/min.

3. Furanoditerpenoids 5--11 {#s0015}
===========================

3.1. Methyl (2S,4R,4aS,6aS,7S,11aR,11bR)-1,2,3,4,4a,5,6,7,11,11a-decahydro-2,7-dihydroxy-4,7-dimethyl-12-oxo-6a,11b-(epoxymethano)phenanthro\[3,2-b\]furan-4-carboxylate (caesalsauteolide) (5) {#s0020}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1D NMR, 2D NMR, and HRESIFTMS spectra of the compound **5** are shown in [Fig. 5](#f0025){ref-type="fig"}a--g.

3.2. (2S,4R,4aS,6aS,7R,11aS,11bS)-1,2,3,4,4a,5,6,6a,7,11,11a,11b-Dodecahydro-2-hydroxy-4-(methoxycarbonyl)-4,7-dimethylphenanthro\[3,2-b\]furan-11b-carboxylic acid (2-hydroxycaesaljapin) (6) {#s0025}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1D NMR, 2D NMR, and HRESIFTMS spectra of the compound **6** are shown in [Fig. 6](#f0030){ref-type="fig"}a--g.

3.3. (2S,4R,4aS,6S,6aS,7R,11aS,11bS)-1,2,3,4,4a,5,6,6a,7,11,11a,11b-Dodecahydro-2,6-dihydroxy-4-(methoxycarbonyl)-4,7-dimethylphenanthro\[3,2-b\]furan-11b-carboxylic acid (2,7-dihydroxycaesaljapin) (7) {#s0030}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1D NMR, 2D NMR, and HRESIFTMS spectra of the compound **7** are shown in [Fig. 7](#f0035){ref-type="fig"}a--g.

3.4. Methyl (2R,4R,4aR,5R,6aS,7R,11aS,11bS,12S)-2,3,4,4a,5,6,6a,7,11,11a-decahydro-2,12-dihydroxy-4,7-dimethyl-1H-5,11b-(epoxymethano)phenanthro\[3,2-b\]furan-4-carboxylate (2-hydroxycaesalacetal) (8) {#s0035}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1D NMR, 2D NMR, and HRESIFTMS spectra of the compound **8** are shown in [Fig. 8](#f0040){ref-type="fig"}a--g.

3.5. Methyl (2R,4R,4aR,5R,6aR,11aS,11bS)-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydro-2,5-dihydroxy-11b-(hydroxymethyl)-4-methyl-7-methylenephenanthro\[3,2-b\]furan-4-carboxylate (caesalsauterol) (9) {#s0040}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1D NMR, 2D NMR, and HRESIFTMS spectra of the compound **9** are shown in [Fig. 9](#f0045){ref-type="fig"}a--g.

3.6. Methyl (2R,4R,4aR,5R,6aR,11aS,11bS)-5-acetoxy-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydro-2-hydroxy-11b-(hydroxymethyl)-4-methyl-7-methylenephenanthro\[3,2-b\]furan-4-carboxylate (6-acetylcaesalsauterol) (10) {#s0045}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1D NMR, 2D NMR, and HRESIFTMS spectra of the compound **10** are shown in [Fig. 10](#f0050){ref-type="fig"}a--g.

3.7. Methyl (2R,4R,4aR,5R,6aR,11aS,11bS)-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydro-2,5-dihydroxy-11b-(hydroxymethyl)-4-methyl-7-oxophenanthro\[3,2-b\]furan-4-carboxylate (norcaesalsauterol) (11) {#s0050}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1D NMR, 2D NMR, and HRESIFTMS spectra of the compound **11** are shown in [Fig. 11](#f0055){ref-type="fig"}a--g.
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